Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
04 12월 2023 - 10:00PM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
PreveCeutical Medical (CSE:PREV)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
PreveCeutical Medical (CSE:PREV)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
PreveCeutical Medical Inc (캐나다 증권거래소)의 실시간 뉴스: 최근 기사 0
More PreveCeutical Medical Inc News Articles
